Category IV indications for therapeutic apheresis: ASFA fourth special issue.
The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue.
Shaz
Beth H
BH
Department of Pathology and Laboratory Medicine, Grady Hospital, Emory University, Atlanta, GA, USA.
Linenberger
Michael L
ML
Bandarenko
Nicholas
N
Winters
Jeffrey L
JL
Kim
Haewon C
HC
Marques
Marisa B
MB
Sarode
Ravindra
R
Schwartz
Joseph
J
Weinstein
Robert
R
Wirk
Ashka
A
Szczepiorkowski
Zbigniew M
ZM
D001781:Blood Component Removal / Q000592:standards; D004194:Disease / Q000145:classification; D006801:Humans; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014481:United States